475570-49-1

Basic information

• Product Name: 1-β-D-[5-O-toluenesulfonyl-2,3-di-O-acetylarabinofuranosyl]-2-nitroimidazole
• Synonyms: 1-β-D-[5-O-toluenesulfonyl-2,3-di-O-acetylarabinofuranosyl]-2-nitroimidazole
• CAS NO: 475570-49-1
• Molecular Weight: 483.456
• Mol File: 475570-49-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-β-D-[5-O-toluenesulfonyl-2,3-di-O-acetylarabinofuranosyl]-2-nitroimidazole(CAS DataBase Reference)
• NIST Chemistry Reference: 1-β-D-[5-O-toluenesulfonyl-2,3-di-O-acetylarabinofuranosyl]-2-nitroimidazole(475570-49-1)
• EPA Substance Registry System: 1-β-D-[5-O-toluenesulfonyl-2,3-di-O-acetylarabinofuranosyl]-2-nitroimidazole(475570-49-1)

Safety Data

• Hazardous Substances Data: 475570-49-1(Hazardous Substances Data)

Upstream product

• 108-24-7 acetic anhydride 
• 98-59-9 p-toluenesulfonyl chloride 
• 639079-77-9 1-β-D-[2-O-acetyl-arabinofuranosyl]-2-nitroimidazole 
• 639079-78-0 1-β-D-[5-O-toluenesulfonyl-2-O-acetyl-arabinofuranosyl]-2-nitroimidazole 
• 461003-95-2 1-β-D-(3,5-O-tetraisopropyldisilyloxy-2-O-trifluoromethanesulfonylribofuranosyl)-2-nitroimidazole 
• 639079-75-7 1-β-D-[3,5-O,O-(1,1,3,3-tetraisopropyldisiloxanyl)-2-O-acetylarabinofuranosyl]-2-nitroimidazole 

Relevant articles and documents

Novel compounds for hypoxic cell therapy and imaging

The present invention provides for compounds suitable for therapeutic treatment of hypoxic tissues, particularly for application in radiotherapy, chemosensitization, radiosensitization. The present invention further provides for compounds suitable for rad

Synthesis of 1-beta-D-(5-deoxy-5-iodoarabinofuranosyl)-2-nitroimidazole (beta-IAZA): a novel marker of tissue hypoxia.

The present work describes the synthesis of the beta-isomer of 1-alpha-D-(5-deoxy-5-iodoarabinofuranosyl)-2-nitroimidazole (IAZA). Radioiodinated IAZA ((123)I-IAZA) has been extensively studied as a radiopharmaceutical for the diagnosis of regional and/or